Search

News Incontinence Affects Mental Health –⁠ Actively Offer Help

Urinary incontinence is not a disease, but a symptom accompanying many illnesses. It is a very serious issue, which is also closely related to the quality of life and mental health of the patient. This is confirmed by the words of Austrian physician and co-founder of the field of neurourology Helmut Madersbacher: “Incontinence does not kill a person, but it kills their life.”

Source: Incontinence 3. 6. 2020

Články časopisu Use of PSA density and multiparametric MRI for indication of prostate biopsy

Author of the article: Miroslav Záleský, Jiří Stejskal, Vanda Adamcová, Jan Hrbáček, Ivo Minárik, Adam Pavličko, Jan Votrubová, Marek Babjuk, Roman Zachoval Source: Česká urologie | 1/2019 10. 4. 2019

News The Patient Will Feel Comfortable Only with a Properly Chosen Absorption Aid

While before the approval of the amendment to the Public Health Insurance Act, it was possible to issue a prescription only for one type of aid firmly tied to a particular level of incontinence, now it is allowed to freely combine aids according to the individual needs of the patient. The modern market offers a wide range of aids −⁠ but how to choose a product that matches specific needs?

Source: Incontinence 27. 2. 2020

Články časopisu Recommendations for psychological assessment before bariatric surgery

Author of the article: Jitka Herlesová, Šárka Slabá, Dana Knappová, Pavel Král, Veronika Staňková, Martin Wagenknecht, Jana Žmolíková Source: Časopis lékařů českých | 3-4/2022 12. 9. 2022

Články časopisu Mycotic infections

Author of the article: MUDr. Matoušková Michaela Source: Urologické listy | 2/2005 2. 1. 2006

News Early Tumor Regression as a Marker of Overall Survival in First-Line Treatment of mCRC

In the treatment of metastatic colorectal cancer (mCRC), prognostic factors besides overall survival (OS) and progression-free survival (PFS) include early tumor regression (ETS) and depth of response (DpR). Japanese authors presented the results of an analysis at the European Society for Clinical Oncology (ESMO) congress in September 2022, which evaluated the correlation between ETS, DpR, and OS/PFS in patients with wild-type RAS mCRC from the PARADIGM study.

Source: Colorectal Cancer 21. 4. 2023

News Monitoring Limits in Prescribing Incontinence Aids is Essential

The amendment to the Public Health Insurance Act, which came into effect in December 2019, brought many changes in the reimbursement of medical aids through prescriptions. The methodology for determining the degree of incontinence has changed, and it is now also possible to combine aids according to the individual needs of the patient. We summarize other novelties related to limits issues in the following text.

Source: Incontinence 29. 2. 2020

News The Choice of Incontinence Aids Matters −⁠ But How Not to Get Lost Among Them?

Despite significant advances in medicine, a large number of patients still struggle with incontinence, which limits their comfort and reduces their quality of life. If treatment options have been exhausted, these patients rely on the use of incontinence aids, and therefore every urologist and general practitioner should be familiar with the current offerings and their applications.

Source: Incontinence 14. 4. 2020

News Central European Expert Consensus on the Treatment of ITP in Adult Patients

In a recently published consensus, experts from Central Europe evaluate the current treatment options for immune thrombocytopenia (ITP) in adult patients and issue 7 recommendations for the administration of thrombopoietin receptor agonists (TPO-RA) in the 2nd line treatment of ITP, based on an analysis of 31 randomized controlled trials.

Source: Immune Thrombocytopenia 15. 4. 2024

News Effective Treatment with Nivolumab in Patients with Negative PD-L1 Expression

Source: Case Studies from Immunooncology 11. 5. 2020

News Thyroid Function During COVID-19 Illness and After Recovery

Acute infection with the SARS-CoV-2 coronavirus has varying impacts on different organ systems of the human body. Until now, it has not been certain how precisely it affects the endocrine system, especially the thyroid gland. The study presented below investigated how thyroid function changes in relation to the course of COVID-19 infection.

Source: Thyroid Disorders 6. 5. 2021

News Pregabalin Relieves Patients with Central Neuropathic Pain

Treatment of central neuropathic pain, whether caused by spinal cord or cerebral damage, is often lengthy and not always successful. Study results show that pregabalin may be a suitable alternative to traditional preparations, affecting not only pain but also the quality of life of patients.

Source: Neuropathic Pain 25. 6. 2020

News Long-term Keto Diet May Damage Our Organs

Source: 5. 12. 2024

News Use of Targeted Therapy with Dupilumab in Patients with Allergic Diseases

Interleukins (IL) 4 and 13 play an important role in the pathogenesis of allergic diseases. Their blockade is therefore a suitable strategy for a number of these conditions. This is offered by the new monoclonal antibody dupilumab (Dupixent), which is approved for the treatment of atopic dermatitis, asthma with type 2 inflammation, and chronic rhinosinusitis with nasal polyposis. Studies are ongoing to evaluate its efficacy in other diseases where type 2 inflammation predominates.

Source: Systemic treatment of atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis – Type 2 inflammation 11. 10. 2020

News Effect of Prostaglandin Analogues With and Without Preservatives on Meibomian Glands in Glaucoma Patients

Prostaglandin analogues (PGA) have become a standard in the treatment of open-angle glaucoma. However, their long-term use may be associated with eye irritation or damage to the Meibomian glands. The study presented below aimed to determine whether these changes are directly caused by PGAs or the preservatives in the eye drops.

Source: Treatment of Glaucoma 31. 3. 2021